370 results on '"Schmidt, Amand F."'
Search Results
2. Disease coverage of human genome-wide association studies and pharmaceutical research and development
3. Comparing the effects of CETP in East Asian and European ancestries: a Mendelian randomization study
4. Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
5. Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
6. Prioritising genetic findings for drug target identification and validation
7. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study
8. Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy
9. A Machine Learning Model to Aid Detection of Familial Hypercholesterolemia
10. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study
11. Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings
12. Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemia
13. The Median and the Mode as Robust Meta-Analysis Estimators in the Presence of Small-Study Effects and Outliers
14. Prioritising genetic findings for drug target identification and validation
15. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study
16. Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
17. Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
18. Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis
19. Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity
20. Unraveling the relationships between alpha- and beta-adrenergic modulation and the risk of heart failure
21. “C1-inhibitor levels and venous thromboembolism: results from a Mendelian randomization study”: reply
22. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies
23. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
24. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
25. Genetic drug target validation using Mendelian randomisation
26. Abstract 15527: Association Between Adrenergic Receptor Modulation and the Risk of Heart Failure: A Two-sample Mendelian Randomization Study
27. Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data
28. QI-452785-2 INDIVIDUALIZED FAMILY SCREENING FOR ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
29. Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity
30. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants
31. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants
32. Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy
33. Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity
34. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants
35. Re : Is the Risk Difference Really a More Heterogeneous Measure?
36. Adjusting for Confounding in Early Postlaunch Settings : Going Beyond Logistic Regression Models
37. Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization
38. Penetrance and Prognosis of MYH7Variant-Associated Cardiomyopathies
39. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants
40. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study
41. Bayesian methods including nonrandomized study data increased the efficiency of postlaunch RCTs
42. Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease
43. Exploring interaction effects in small samples increases rates of false-positive and false-negative findings: results from a systematic review and simulation study
44. Justification of exclusion criteria was underreported in a review of cardiovascular trials
45. Exploring the Role of Plasma Lipids and Statins Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study
46. Differences in interaction and subgroup-specific effects were observed between randomized and nonrandomized studies in three empirical examples
47. Unravelling the Difference Between Men and Women in Post-CABG Survival
48. Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings
49. Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemia
50. Impact of Selection Bias on Estimation of Subsequent Event Risk
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.